Font Size: a A A

Analysis Of Immune Reconstitution In Adult Undergoing Non-myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation And Graft-versus-Host Disease And The Th1/Th2 Paradigm

Posted on:2004-08-05Degree:DoctorType:Dissertation
Country:ChinaCandidate:H F GuoFull Text:PDF
GTID:1104360125460834Subject:Internal medicine hematology
Abstract/Summary:PDF Full Text Request
The effect of nonmyeloablative procedures on the pace of post-transplant immune reconstitution is unknown. The aim of this work was to investigate the immune status of patients with leukemia following non-myeloablative allogeneic peripheral blood stem cell transplantation (NST). Ten adult underwent NST from HLA-identical (n=8) or part of antigen-matched sibling donors were enrolled in the study. Patients were analyzed 1, 3 and 12 months after transplant. Recovery of T-, B-, and NK-lymphocyte subsets, immunoglobulin levels, proliferative in vitro response to mitogens, as well as cytotoxic activities, was investigated.Results demostrated that the absolute number of CD3+and CD8+T cells, B lymphocytes, as well as the proliferative response to T-cell mitogens, recovered with time after transplantation.CD8+T cell and B cell recovered to the normal range by 3 months.CD4+T cell counts remained below normal up to 1 year after transplantation. Recovery of NK cell number and innate cytotoxic activities was fast. IgG and IgM levels were within normal range at 1 month post transplant. We suggest the different behavior inthe immune reconstitution of CDS subset after NST may be favored by an extrathymic origin of these cells, while CD44 subset recovery which is thymus-dependent is impaired in adult population. We conclude that stem cell engraftment following nonmyeloablative conditioning may result in early immune reconstitution. We speculate that NST may lead to faster development of effective immune responses against residual host-type malignant and abnormal non-malignant hematopoietic cells.
Keywords/Search Tags:non-myeloablative, peripheral blood, immune reconstitution, allogeneic stem cell transplantation.
PDF Full Text Request
Related items
Comparison Of Early Immune Reconstitution Of Adults With Acute Leukemia After Umbilical Cord Blood Transplantation And Hla-Matched Sibling Donor Allogeneic Peripheral Stem-Cell Transplantation
The Study Of Reconstitution In Bone Marrow Immune Niche After Allogeneic Stem Cell Transplantation
The Research Of Related HLA-haploidentical Without Ex Vivo T Cell Depletion High Dose Peripheral Blood Hematopoietic Stem Cell Transplantation To Treat Hematologic Malignancies And Relationship Between AGVHD And B7 Family After Transplantation
Mononuclear Cells Count Can Reliably Predict Hematopoietic Reconstitution After Allogeneic Peripheral Blood Stem Cell Transplantation
A Clinical Analysis Of Non-myeloablative Allogeneic Bone Marrow Combined With Peripheral Blood Hematopoietic Stem Cell Transplantation For Severe Aplastic Anemia
Contrasting The Clinical Outcome And Immunological Reconstitution From HLA Haploidentical And HLA-matched Peripheral Blood Hematopoietic Stem Cell Transplantation Without In Vitro T-cell Depletion
Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation And The Correlation Between CD4+CD25highFOXP3+and GVHD
Non-myeloablative Allogeneic Stem Cell Transplantation For Treatment Of The Mds The-raeb1 Cases And Literature Review,
Immune Reconstitution Kinetics And Its Impact On Outcome After Umbilical Cord Blood Transplantation With Myeloablative Regimen Without Antithymocyte Globulin
10 Clinical And Experimental Study Of HLA Haploidentical Family Donor Allogeneic Peripheral Blood Stem Cell Transplantation For The Treatment Of Hematologic Malignancies